세계의 의료 소프트웨어 시장 보고서(2025년)
Medical Software Global Market Report 2025
상품코드 : 1825454
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

의료 소프트웨어 시장의 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 연평균 복합 성장률(CAGR) 13.4%로 1,116억 5,000만 달러로 성장할 전망입니다. 예측기간의 성장 배경으로는 전자의료기록(EHR) 및 전자의료기록(EMR) 시스템의 도입 확대, 데이터 주도형 의사결정 도구에 대한 수요 증가, 원격의료 및 원격 환자 모니터링 솔루션에 대한 주목 고조, 의료 서비스의 디지털화를 추진하는 정부의 대처 등이 있습니다. 예측기간의 주요 동향으로는 의료 소프트웨어에서 클라우드 기반 솔루션 채택, 인공지능(AI) 및 머신러닝(ML) 기술의 통합 증가, 맞춤의료, 원격의료 및 가상 케어 플랫폼 수요 증가, 상호운용성 표준 및 데이터 교환 프로토콜의 중시, 모바일 헬스(m헬스) 애플리케이션과 웨어러블 디바이스의 등장 등이 있습니다.

향후 5년간의 예측 성장률 13.4%는 이 시장의 과거 예측에서 0.6% 소폭 감소한 수치입니다. 이러한 성장세 둔화는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세 장벽은 이스라엘과 인도에서 개발된 인공지능(AI) 탑재 진단 플랫폼과 클라우드 기반 전자의료기록(EHR) 시스템의 비용을 상승시킴으로써 미국의 건강 관리 시스템을 저해하고 디지털 건강 채용을 제한하여 IT 예산의 압박을 높일 것으로 예측됩니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 예상됩니다.

의료 소프트웨어 시장의 성장은 고령화 인구 증가와 만성질환 증가에 의해 견인될 것으로 예측됩니다. 고령화는 인구에서 차지하는 고령자의 비율이 높아지는 현상이며, 만성질환이란 일반적으로 치유는 불가능하지만, 적절한 치료와 생활습관의 개선에 의해 관리할 수 있는 장기적인 건강 상태입니다. 평균 수명이 늘어나고, 앉기 쉬운 생활, 식생활의 흐트러짐, 흡연, 과도한 음주 등 다양한 라이프스타일의 선택에 의해 이러한 요인은 모두 증가 경향에 있습니다. 의료 소프트웨어는 만성질환을 가진 노인 관리를 강화하는 데 사용되며 개인화 치료, 질병 관리 및 건강 모니터링을 지원합니다. 이 기술은 적극적인 건강 모니터링과 효율적인 병리 관리를 지원하여 노인 케어의 질과 전반적인 웰빙을 모두 향상시키는 데 도움이 됩니다. 예를 들어 미국 비영리단체인 인구문제연구소(PRB)는 2024년 1월 65세 이상의 미국인 수가 2022년 5,800만명에서 2050년에는 8,200만명으로 47% 증가할 것으로 예측했습니다. 이 그룹은 미국 인구의 17%에서 23%를 차지합니다. 또한 2024년 4월 영국 알러지협회가 발표한 보고서에 따르면 영국에서는 2,100만 명 이상이 알러지의 영향을 받았으며, 2022년에는 가장 흔한 만성질환이 되었습니다. 2026년까지는 유럽 인구의 절반이 적어도 하나의 알러지로 고통받을 것으로 예측됩니다. 그 결과 고령화와 만성질환 증가가 의료 소프트웨어 수요에 박차를 가하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

CSM
영문 목차

영문목차

Medical software encompasses specialized applications and platforms tailored to aid healthcare professionals in diverse aspects of patient care within medical facilities. Its purpose is to streamline the management of patient records, facilitate diagnosis, treatment planning, and support healthcare administration.

The primary categories of medical software include electronic health records (EHR), medical practice management software, telemedicine platforms, medical billing and coding solutions, clinical decision support systems (CDSS), among others. Electronic health records (EHR) serve as digital counterparts to traditional paper charts, enabling seamless access to patient information across various healthcare settings such as hospitals, clinics, and ambulatory care centers. These solutions cater to multiple end users including healthcare providers, payers, and patients themselves.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The medical software market research report is one of a series of new reports from The Business Research Company that provides medical software market statistics, including the medical software industry global market size, regional shares, competitors with medical software market share, detailed medical software market segments, market trends, and opportunities, and any further data you may need to thrive in the medical software industry. This medical software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The medical software market size has grown rapidly in recent years. It will grow from $58.94 billion in 2024 to $67.54 billion in 2025 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to the implementation of healthcare information technology (HIT) solutions, adoption of secure and compliant software systems, increasing focus on interoperability and data exchange, advances in medical imaging and diagnostic software, and growing demand for healthcare analytics.

The medical software market size is expected to see rapid growth in the next few years. It will grow to $111.65 billion in 2029 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to the increasing adoption of electronic health records (EHR) and electronic medical records (EMR) systems, growing demand for data-driven decision-making tools, rising focus on telemedicine and remote patient monitoring solutions, and government initiatives promoting the digitization of healthcare services. Major trends in the forecast period include the adoption of cloud-based solutions for medical software, increasing integration of artificial intelligence (AI) and machine learning (ML) technologies, personalized medicine, growing demand for telehealth and virtual care platforms, emphasis on interoperability standards and data exchange protocols, and rise of mobile health (mHealth) applications and wearable devices.

The forecast of 13.4% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. healthcare system by increasing the cost of Artificial intelligence(AI)-powered diagnostic platforms and cloud-based Electronic Health Record(EHR) systems developed in Israel and India, thereby limiting digital health adoption and elevating IT budget pressures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the medical software market is projected to be driven by the increasing aging population and the rise of chronic diseases. The aging population refers to a higher percentage of elderly individuals within a given population, while chronic diseases are long-term health conditions that are typically not curable but can be managed through appropriate treatment and lifestyle changes. Both of these factors are on the rise due to longer life expectancies and various lifestyle choices, such as sedentary behavior, poor diets, smoking, and excessive alcohol consumption. Medical software is used to enhance care for the elderly with chronic diseases, helping with personalized treatment, disease management, and health monitoring. This technology helps improve both the quality of care and the overall well-being of older individuals by supporting proactive health monitoring and efficient management of their conditions. For example, the Population Reference Bureau (PRB), a U.S.-based nonprofit, projected in January 2024 that the number of Americans aged 65 and older will grow from 58 million in 2022 to 82 million by 2050, representing a 47% increase. This group will make up 23% of the U.S. population, up from 17%. Additionally, a report from Allergy UK in April 2024 noted that more than 21 million people in the UK are affected by allergies, which became the most common chronic health condition in 2022. By 2026, it is expected that half of Europe's population will suffer from at least one allergy. As a result, both the aging population and the rise in chronic diseases are fueling the demand for medical software.

Leading companies in the medical software market are concentrating on creating advanced technological solutions, such as smart health assistants, to alleviate the burden on healthcare staff and boost operational efficiency by utilizing AI to simplify both clinical and administrative tasks. Smart health assistants are AI-powered digital tools designed to help individuals manage their health by providing services like scheduling appointments and reminding users to take their medications. For example, in October 2024, Microsoft Corporation, a U.S.-based technology company, introduced the Health-Care AI Suite to aid healthcare organizations in more efficiently developing AI applications. This suite includes tools like medical imaging models, AI agents, and automated documentation solutions, all designed to reduce clinician workloads and improve productivity. The Health-Care AI Suite is especially important as it enables healthcare systems to streamline administrative processes, enhance data accuracy, and provide smoother access to clinical information, helping to tackle widespread issues such as clinician burnout and inefficiencies in documentation.

In April 2024, GE HealthCare Technologies Inc., a prominent US-based medical technology company, completed the acquisition of MIM Software for an undisclosed sum. This strategic move aims to strengthen GE HealthCare Technologies' support for provider needs by providing established solutions that simplify, streamline, and automate essential tasks, thereby optimizing workflows. MIM Software, based in the US, specializes in medical software solutions for radiation oncology, nuclear medicine, and medical radiology, among others. The acquisition aligns with GE HealthCare Technologies' commitment to delivering innovative solutions that meet the evolving demands of the healthcare industry.

Major companies operating in the medical software market are McKesson Corporation, OptumHealth, Dell Technologies Inc., International Business Machines Corporation (IBM), Siemens Healthineers, Koninklijke Philips NV, GE HealthCare Technologies, Henry Schein Inc., Quest Diagnostics Incorporated, Cerner Corporation, Epic Systems Corporation, Lexmark International Inc., Athenahealth Inc., CompuGroup Medical SE & Co KGaA, eClinicalWorks, Allscripts Healthcare Solutions Inc., Greenway Health LLC, Computer Programs and Systems Inc., Sunquest Information Systems Inc., Merge Healthcare Incorporated, NextGen Healthcare Inc., First Databank Inc., CureMD Healthcare, Practice Fusion Inc., Updox LLC

North America was the largest region in the medical software market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical software market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical software market includes revenues earned by entities by providing services, such as telehealth and telemedicine solutions, clinical decision support systems, health information exchange (HIE), and patient portals. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Software Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on medical software market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for medical software ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical software market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Medical Software Market Characteristics

3. Medical Software Market Trends And Strategies

4. Medical Software Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Medical Software Growth Analysis And Strategic Analysis Framework

6. Medical Software Market Segmentation

7. Medical Software Market Regional And Country Analysis

8. Asia-Pacific Medical Software Market

9. China Medical Software Market

10. India Medical Software Market

11. Japan Medical Software Market

12. Australia Medical Software Market

13. Indonesia Medical Software Market

14. South Korea Medical Software Market

15. Western Europe Medical Software Market

16. UK Medical Software Market

17. Germany Medical Software Market

18. France Medical Software Market

19. Italy Medical Software Market

20. Spain Medical Software Market

21. Eastern Europe Medical Software Market

22. Russia Medical Software Market

23. North America Medical Software Market

24. USA Medical Software Market

25. Canada Medical Software Market

26. South America Medical Software Market

27. Brazil Medical Software Market

28. Middle East Medical Software Market

29. Africa Medical Software Market

30. Medical Software Market Competitive Landscape And Company Profiles

31. Medical Software Market Other Major And Innovative Companies

32. Global Medical Software Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Medical Software Market

34. Recent Developments In The Medical Software Market

35. Medical Software Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기